Page 3 - Biosolution Baltimore News Today

Health Canada says it is holding the 300,000 Johnson & Johnson COVID-19 vaccine doses that arrived in the country on Wednesday due to a possible quality control issue.

NEW YORK, April 29, 2021 /PRNewswire/ --

Share this article NEW YORK, April 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period") of the important June 18, 2021 lead plaintiff deadline. SO WHAT: If you purchased Emergent BioSolutions securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...

Canada says AstraZeneca safe from Baltimore plant once closed 30 Apr 2021, 05:49 GMT+10 OTTAWA, Canada: Canadas national health agency has pronounced the AstraZeneca vaccine coming from Baltimore as being safe and of high quality. This follows a review of 1.5 million doses of the AstraZeneca Plc COVID-19 vaccine imported from Emergent BioSolutions Baltimore manufacturing plant. In April, the U.S. Food and Drug Administration had halted AstraZeneca from using the plant, as well as stopping Johns...

Examining Our COVID-19 Response: Using Lessons Learned to Address Mental Health and Substance Use Disorders” 10:00 a.m. Senate Appropriations Committee Subcommittee on the Interior, Environment, and Related Agencies Hearing: “Addressing Health Disparities in Indian Country: Review of the Indian Health Service’s COVID Response and Future Needs” 10:00 a.m. Senate Appropriations Committee Subcommittee on Military Construction, Veterans Affairs, and Related Agencies Hearing: “VA Telehea...

Canada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications.

Health Canada says the 1.5 million doses of the AstraZeneca Plc COVID-19 vaccine imported from Emergent BioSolutions Baltimore facility were safe and met quality specifications.

Monday, 26 Apr 2021 08:31 AM MYT A vial and syringe are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. — Reuters pic Subscribe to our Telegram channel for the latest updates on news you need to know. OTTAWA, April 26 — Canada’s health department said on Sunday the 1.5 million doses of the Astrazeneca Plc Covid-19 vaccine imported from Emergent BioSolutions’ Baltimore facility were safe and met quality specifications. The US Food and Drug Admin...

Share this article NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 18, 2021. SO WHAT: If you purchased Emergen...

NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 18, 2021. - Advertisement - SO WHAT: If you purchased Emerge...